Johan Bodegard
Overview
Explore the profile of Johan Bodegard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson L, Bayes-Genis A, Bodegard J, Mullin K, Gustafsson S, Rosano G, et al.
Eur Heart J
. 2025 Feb;
PMID: 39935142
Background And Aims: Ambulatory patients presenting with signs or symptoms of heart failure (HF) should undergo natriuretic peptide testing. Rates of death, HF hospitalization, and healthcare costs were examined in...
2.
Metsarinne K, Bodegard J, Toppila I, Uusi-Rauva K, Frederiksen L, Brinkmann S
Nephrol Dial Transplant
. 2024 Nov;
PMID: 39510970
Background: Real-world evidence on the management of chronic kidney disease (CKD) with and without type 2 diabetes (T2D) is limited. This study described the characteristics, treatment, and disease burdenin patients...
3.
Svensson M, Tangri N, Bodegard J, Adamsson Eryd S, Thuresson M, Sofue T
Clin Kidney J
. 2024 Aug;
17(8):sfae100.
PMID: 39165293
Background: We compared kidney and cardiorenal protection in patients without type 2 diabetes across urine albumin-creatinine ratio (UACR) levels after initiation on dapagliflozin for the treatment of chronic kidney disease...
4.
Sundstrom J, Norhammar A, Karayiannides S, Bodegard J, Gustafsson S, Cars T, et al.
BMJ Open
. 2024 Apr;
14(4):e074064.
PMID: 38643002
Objectives: Identify the windows of opportunity for the diagnosis of chronic kidney disease (CKD) and the prevention of its adverse outcomes and quantify the potential population gains of such prevention....
5.
Christersson M, Gustafsson S, Lampa E, Almstedt M, Cars T, Bodegard J, et al.
J Am Heart Assoc
. 2024 Apr;
13(8):e032257.
PMID: 38591322
Background: Heart failure guidelines have recently introduced a narrow category with mildly reduced left ventricular ejection fraction (LVEF) (heart failure with mildly reduced ejection fraction; LVEF 41%-49%) between the previous...
6.
Sundstrom J, Arnlov J, Karayiannides S, Bodegard J, Ersmark K, Gustafsson S, et al.
ESC Heart Fail
. 2024 Feb;
11(3):1377-1388.
PMID: 38311878
Aims: This study aimed to characterize a contemporary population with subtypes of incident or prevalent heart failure (HF) based on reduced (HFrEF), mildly reduced, or preserved (HFpEF) left ventricular ejection...
7.
Tangri N, Svensson M, Bodegard J, Adamsson Eryd S, Thuresson M, Gustafsson S, et al.
Kidney360
. 2024 Feb;
5(3):352-362.
PMID: 38297439
No abstract available.
8.
Bozkurt B, Savarese G, Adamsson Eryd S, Bodegard J, Cleland J, Khordoc C, et al.
JACC Heart Fail
. 2023 Jun;
11(10):1320-1332.
PMID: 37354145
Background: There are few contemporary data on outcomes, costs, and treatment following a hospitalization for heart failure (hHF) in epidemiologically representative cohorts. Objectives: This study sought to describe rehospitalizations, hospitalization...
9.
Ritsinger V, Bodegard J, Kristofi R, Thuresson M, Nathanson D, Nystrom T, et al.
BMJ Open
. 2023 Apr;
13(4):e069037.
PMID: 37117003
Objectives: To explore how cardiorenal disease (CRD; heart failure and/or chronic kidney disease) impacted mortality in men and women hospitalised for COVID-19 during the first three waves of the pandemic...
10.
Norhammar A, Bodegard J, Vanderheyden M, Tangri N, Karasik A, Maggioni A, et al.
Heart
. 2023 Feb;
109(7):548-556.
PMID: 36781285
Objective: Digital healthcare systems could provide insights into the global prevalence of heart failure (HF). We designed the CardioRenal and Metabolic disease (CaReMe) HF study to estimate the prevalence, key...